Caricamento...

Current clinical evidence on pioglitazone pharmacogenomics

Pioglitazone is the most widely used thiazolidinedione and acts as an insulin-sensitizer through activation of the Peroxisome Proliferator-Activated Receptor-γ (PPARγ). Pioglitazone is approved for use in the management of type 2 diabetes mellitus (T2DM), but its use in other therapeutic areas is in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kawaguchi-Suzuki, Marina, Frye, Reginald F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3840328/
https://ncbi.nlm.nih.gov/pubmed/24324437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2013.00147
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !